Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.1.26.9 (ribonuclease)
 6,589 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The beta subunit of thyroid-stimulating hormone (TSHbeta) has been isolated and sequenced in many species, including several mammals and the frog, but not in any avian species. Therefore, the objective of this study was to isolate and sequence a cDNA for chicken TSHbeta. Degenerate oligonucleotide primers were designed, based on conserved regions of TSHbeta from four other species, and used for reverse transcription and polymerase chain reaction amplification of a cDNA fragment from total cellular RNA of pituitary glands from 7-day-old chicks. The remaining sequence was completed by rapid amplification of cDNA ends. The predicted amino acid sequence was 70. 4% identical between bovine and chicken, 69.6% identical between chicken and rat, and 57.4% identical between chicken and frog. To test for tissue specificity of the cDNA, total cellular RNA samples from testicle, liver, pituitary, lung, and heart were analyzed by Northern blot. The 32P-labeled antisense riboprobe hybridized to an RNA species of approximately 600-700 bases in pituitary RNA alone, corresponding with the length of TSHbeta mRNA in other species. Gene expression in Day 1 posthatch chickens was then analyzed by ribonuclease protection assay. Anterior pituitary cells of Day 1 chickens were treated for 20 to 24 hr in serum-free medium alone or with medium containing either thyrotropin-releasing hormone (TRH) (10(-8) M) or triiodothyronine (T3) (10(-9) M). The RNA was then harvested from these cells and hybridized with a 32P-labeled antisense riboprobe. Treatment with TRH had no effect on TSHbeta mRNA levels, while T3 significantly decreased (P < 0.05; n = 6 trials) TSHbeta mRNA levels by 45%. Taken together these results indicate that the cDNA sequence derived represents chicken TSHbeta mRNA, and that TSHbeta gene expression is downregulated by thyroid hormones as it is in mammals.
 ...
PMID:Cloning and sequence analysis of a cDNA for the beta subunit of chicken thyroid-stimulating hormone. 924 26

Prior research indicates that growth hormone (GH) cell differentiation can be induced prematurely by treatment with glucocorticoids in vitro and in vivo. However, the nature of these responses has not been fully characterized. In this study, the time course of corticosterone induction of GH-secreting cells in cultures of chicken embryonic pituitary cells, responsiveness of differentiated somatotrophs to GH secretagogues, localization of somatotroph precursor cells within the pituitary gland, and the effect of corticosterone on GH gene expression were determined to better define the involvement of glucocorticoids in somatotroph recruitment during development. Anterior pituitary cells from embryonic day 12 chicken embryos were cultured in 10(-9) M corticosterone for 4 to 48 h and were then subjected to reverse haemolytic plaque assays (RHPAs) for GH. Corticosterone treatment for as short as 16 h increased the percentage of GH cells compared with the control. When corticosterone was removed after 48 h and cells were cultured for an additional 3 days in medium alone, the percentage of GH secretors decreased but remained greater than the proportion of somatotrophs among cells that were never treated with corticosterone. To determine if prematurely differentiated somatotrophs were responsive to GH secretagogues, cells were exposed to corticosterone for 48 h and then subjected to GH RHPAs in the presence or absence of GH-releasing hormone (GHRH) or thyrotropin-releasing hormone (TRH). Approximately half of the somatotrophs induced to differentiate with corticosterone subsequently released more GH in response to GHRH and TRH than in their absence. The somatotroph precursor cells were localized within the anterior pituitary by culturing cells from the caudal lobe and cephalic lobe of the anterior pituitary separately. Corticosterone induction of GH cells was substantially greater in cultures derived from the caudal lobe of the anterior pituitary, where somatotroph differentiation normally occurs. GH gene expression was evaluated by ribonuclease protection assay and by in situ hybridization. Corticosterone increased GH mRNA in cultured cells by greater than fourfold. Moreover, corticosterone-induced somatotroph differentiation involved GH gene expression in cells not expressing GH mRNA previously, and the extent of somatotroph differentiation was augmented by treatment with GHRH in combination with corticosterone. We conclude that corticosterone increases the number of GH-secreting cells within 16 h, increases GH gene expression in cells formerly not expressing this gene, confers somatotroph sensitivity to GHRH and TRH, and induces GH production in a precursor population found primarily in the caudal lobe of the anterior pituitary, a site consistent with GH localization in adults. These findings support the hypothesis that glucocorticoids function to induce the final stages in the differentiation of fully functional somatotrophs from cells previously committed to this lineage.
 ...
PMID:Somatotroph recruitment by glucocorticoids involves induction of growth hormone gene expression and secretagogue responsiveness. 1137 20

Responsiveness of the hypothalamo-pituitary-adrenal axis is decreased during pregnancy. Therefore, the objective of the present study was to determine if responsiveness at the level of individual corticotrophs to corticotropin-releasing hormone (CRH) or arginine vasopressin (AVP) is decreased during pregnancy in sheep. Anterior pituitaries (APs) were collected from pregnant and nonpregnant ewes. Half of the APs were dispersed, and cells were placed on immobilon and treated with vehicle, CRH (10 nM), or AVP (100 nM) for 2 h. Cells were then fixed and incubated with ACTH or pro-opiomelanocortin (POMC) antibodies. The percentage of cells staining positive for immunoreactive (ir) ACTH or POMC, the percentage of cells secreting irACTH or POMC, and the area of irACTH or POMC secretion were measured. RNA was extracted from the other half of the APs to quantify CRH type 1 (CRH-R1) and vasopressin type 1b (V1b) receptor mRNA by ribonuclease protection assay. CRH treatment increased the percentage of corticotrophs with relatively large areas of irACTH and POMC secretion in nonpregnant, but not in pregnant, ewes. AVP treatment significantly increased the percentage of irACTH- and POMC-secreting cells in nonpregnant, but not in pregnant, ewes. V1b receptor mRNA, but not CRH-R1 receptor mRNA, was significantly decreased during pregnancy. These results suggest that corticotroph responsiveness to CRH and AVP is decreased during pregnancy in sheep. Therefore, reduced corticotroph responsiveness may contribute to stress hyporesponsivity during pregnancy.
 ...
PMID:Attenuation of corticotropin-releasing hormone and arginine vasopressin responsiveness during late-gestation pregnancy in sheep. 1202 Oct 66